Mark Willmot

2.2k total citations
14 papers, 1.2k citations indexed

About

Mark Willmot is a scholar working on Epidemiology, Cardiology and Cardiovascular Medicine and Neurology. According to data from OpenAlex, Mark Willmot has authored 14 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 5 papers in Cardiology and Cardiovascular Medicine and 3 papers in Neurology. Recurrent topics in Mark Willmot's work include Acute Ischemic Stroke Management (9 papers), Antiplatelet Therapy and Cardiovascular Diseases (3 papers) and Stroke Rehabilitation and Recovery (2 papers). Mark Willmot is often cited by papers focused on Acute Ischemic Stroke Management (9 papers), Antiplatelet Therapy and Cardiovascular Diseases (3 papers) and Stroke Rehabilitation and Recovery (2 papers). Mark Willmot collaborates with scholars based in United Kingdom, Denmark and Croatia. Mark Willmot's co-authors include Philip M. Bath, Jo Leonardi‐Bee, Laura J. Gray, Claire L. Gibson, Seán Murphy, Nikola Sprigg, Liancheng Zhao, Marion Walker, Joanna M. Wardlaw and Anand Dixit and has published in prestigious journals such as PLoS ONE, Stroke and Free Radical Biology and Medicine.

In The Last Decade

Mark Willmot

14 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Willmot United Kingdom 11 569 459 232 222 174 14 1.2k
Joyce S. Balami United Kingdom 14 830 1.5× 600 1.3× 101 0.4× 328 1.5× 342 2.0× 36 1.6k
Dolors Giralt Spain 22 457 0.8× 188 0.4× 147 0.6× 328 1.5× 166 1.0× 46 1.2k
Romesh Markus Australia 21 733 1.3× 463 1.0× 98 0.4× 266 1.2× 320 1.8× 39 1.4k
Dae‐Il Chang South Korea 18 418 0.7× 251 0.5× 139 0.6× 187 0.8× 246 1.4× 78 1.2k
Stefan T. Gerner Germany 21 590 1.0× 815 1.8× 131 0.6× 173 0.8× 61 0.4× 86 1.4k
Meaghan Roy-O’Reilly United States 18 309 0.5× 209 0.5× 80 0.3× 401 1.8× 108 0.6× 24 1.1k
Naoki Oyama Japan 17 303 0.5× 179 0.4× 167 0.7× 275 1.2× 244 1.4× 44 1.1k
Yasutaka Tanaka Japan 17 292 0.5× 127 0.3× 126 0.5× 96 0.4× 190 1.1× 49 1.0k
Takemori Yamawaki Japan 19 212 0.4× 466 1.0× 81 0.3× 154 0.7× 184 1.1× 75 1.2k

Countries citing papers authored by Mark Willmot

Since Specialization
Citations

This map shows the geographic impact of Mark Willmot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Willmot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Willmot more than expected).

Fields of papers citing papers by Mark Willmot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Willmot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Willmot. The network helps show where Mark Willmot may publish in the future.

Co-authorship network of co-authors of Mark Willmot

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Willmot. A scholar is included among the top collaborators of Mark Willmot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Willmot. Mark Willmot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Muir, Keith W., Diederik Bulters, Mark Willmot, et al.. (2020). Intracerebral implantation of human neural stem cells and motor recovery after stroke: multicentre prospective single-arm study (PISCES-2). Journal of Neurology Neurosurgery & Psychiatry. 91(4). 396–401. 125 indexed citations
2.
Perry, Richard, Craig J. Smith, Christine Roffe, et al.. (2020). Characteristics and outcomes of COVID-19 associated stroke: a UK multicentre case-control study. Journal of Neurology Neurosurgery & Psychiatry. 92(3). 242–248. 62 indexed citations
3.
Appleton, Jason P., Andreea Ilinca, Arne Lindgren, et al.. (2015). Improving the likelihood of neurology patients being examined using patient feedback. BMJ Quality Improvement Reports. 4(1). u209610.w4063–u209610.w4063. 2 indexed citations
4.
Sprigg, Nikola, Laura J. Gray, Timothy J. England, et al.. (2008). A Randomised Controlled Trial of Triple Antiplatelet Therapy (Aspirin, Clopidogrel and Dipyridamole) in the Secondary Prevention of Stroke: Safety, Tolerability and Feasibility. PLoS ONE. 3(8). e2852–e2852. 27 indexed citations
5.
Sprigg, Nikola, Mark Willmot, Laura J. Gray, et al.. (2007). Amphetamine increases blood pressure and heart rate but has no effect on motor recovery or cerebral haemodynamics in ischaemic stroke: a randomized controlled trial (ISRCTN 36285333). Journal of Human Hypertension. 21(8). 616–624. 28 indexed citations
6.
Sprigg, Nikola, Philip M. Bath, Liancheng Zhao, et al.. (2006). Granulocyte-Colony–Stimulating Factor Mobilizes Bone Marrow Stem Cells in Patients With Subacute Ischemic Stroke. Stroke. 37(12). 2979–2983. 94 indexed citations
7.
Gray, Laura J., et al.. (2006). Effect of Nitric Oxide Donors on Blood Pressure and Pulse Pressure in Acute and Subacute Stroke. Journal of Stroke and Cerebrovascular Diseases. 15(6). 245–249. 10 indexed citations
8.
Willmot, Mark, et al.. (2006). Transdermal Glyceryl Trinitrate Lowers Blood Pressure and Maintains Cerebral Blood Flow in Recent Stroke. Hypertension. 47(6). 1209–1215. 84 indexed citations
9.
Willmot, Mark, Claire L. Gibson, Laura J. Gray, Seán Murphy, & Philip M. Bath. (2005). Nitric oxide synthase inhibitors in experimental ischemic stroke and their effects on infarct size and cerebral blood flow: A systematic review. Free Radical Biology and Medicine. 39(3). 412–425. 114 indexed citations
10.
Willmot, Mark, Laura J. Gray, Claire L. Gibson, Seán Murphy, & Philip M. Bath. (2005). A systematic review of nitric oxide donors and l-arginine in experimental stroke; effects on infarct size and cerebral blood flow. Nitric Oxide. 12(3). 141–149. 135 indexed citations
11.
Zhao, Liancheng, Sally Fletcher, Jo Leonardi‐Bee, et al.. (2005). Effects of aspirin, clopidogrel and dipyridamole administered singly and in combination on platelet and leucocyte function in normal volunteers and patients with prior ischaemic stroke. Thrombosis and Haemostasis. 93(3). 527–534. 17 indexed citations
12.
Willmot, Mark, Liancheng Zhao, Stan Heptinstall, & Philip M. Bath. (2004). Triple antiplatelet therapy for secondary prevention of recurrent ischemic stroke. Journal of Stroke and Cerebrovascular Diseases. 13(3). 138–140. 8 indexed citations
13.
Willmot, Mark, Jo Leonardi‐Bee, & Philip M. Bath. (2003). High Blood Pressure in Acute Stroke and Subsequent Outcome. Hypertension. 43(1). 18–24. 437 indexed citations
14.
Willmot, Mark. (2000). NHSnet in Scottish primary care: lessons for the future. BMJ. 321(7265). 878–881. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026